Skye Bioscience Announces Participation at Upcoming Investor Conferences #Biotechnology #Cannabis #Chemicals #Investing #Marijuana #MarijuanaStocks #Medical #OTC #OTCMarkets #OTCStocks #Pharmaceutical #Pharmaceuticals #PotStocks #SKYE #SKYED

San Diego, California--(Newsfile Corp. - September 22, 2023) - Skye Bioscience, Inc. (OTCQB: SKYED) ("Skye" or the "Company"), a pharmaceutical company developing proprietary medicines that modulate the endocannabinoid system to treat diseases with inflammatory, fibrotic, and metabolic processes, with a current focus on the CB1 pathway, announced today that it will be presenting a corporate overview at the 2023 Cantor Global Healthcare Conference and the 16th Annual LD Micro Main Event.2023...
http://dlvr.it/SwT1lk

Comments

Popular posts from this blog

SEC Investor Advisory Committee to Discuss Exempt Offerings and Accredited Investors at September 21 Meeting #Banking #FinancialServices

Cleantek Industries Inc. Announces a Twelve-Month Extension of Credit Facility #CTEK.CA #CTEK.V #GLKFF #Investing #OTC #OTCMarkets #OTCStocks #SmallCaps #TSXV #Technology

Hearts Connect along the Silk Road, International Voluntary Service Seminar Held in Nanjing #